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Introduction
Dilated cardiomyopathy (DCM) is a major cause of
heart failure and sudden cardiac death. About one third
of DCM is familial. Several DCM disease genes have
been identified, many of them limited to only single
individuals or families. A/C gene (LMNA) is sofar the
most significant disease gene of DCM. Cardiac magnetic
resonance imaging (MRI) plays an important role in
characterization and risk stratification of patients with
DCM. About one third of DCM patients have demon-
strated mid-myocardial linear enhancement on DE-MRI
in a non-coronary distribution, due to fibrosis.
Purpose
The purpose of this study was to identify myocardial
delayed enhancement (DE) pattern, regional wall motion
abnormalities, ventricular volumes and function with
cardiac MRI in asymptomatic or mildly symptomatic
carriers of LMNA mutations causing DCM. Secondly,
we investigated the possible association between locali-
zation of myocardial fibrosis in MRI and conduction
abnormalities documented with electrocardiography.
Methods
Seventeen asymptomatic or mildly symptomatic LMNA
mutation carriers and 14 healthy controls underwent car-
diac MRI. DE-MRI was performed to evaluate myocardial
fibrosis. The location, pattern and extent of DE in the left
ventricular myocardium were visually estimated. Cine
MRI was performed to study regional wall motion and
global function of ventricles.
Results
Out of 17 patients, 15 exhibited myocardial fibrosis
(88%). Among the total of 289 myocardial segments, DE
was observed in 47 (16%). In all patients DE occurred in
the basal or mid-ventricular septal wall (Figure 1). Fibro-
sis caused segmental wall motion abnormalities and cor-
relation was strong when compared to the degree of DE
(p<0,001) (Table 1). Myocardial DE associated with con-
duction abnormalities. Eleven patients with conduction
abnormalities and two with atrial fibrillation had
enhancement in the basal and mid-ventricular septum.
Significant LV ventricular dilatation and decrease in sys-
tolic function in both ventricles was found compared to
controls (Table 2).
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Figure 1 Delayed enhanced cardiac MRI of a 32- year old male
with A/C lamin mutation DCM. Four-chamber (a) and short axis (b)
views of the heart show typical mid-myocardial and linear
enhancement of the basal septum.
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In the early stage of DCM caused by a lamin A/C gene
mutation cardiac conduction abnormalities and mildly
depressed LV function are common but also other car-
diac diseases, like sarcoidosis, may produce a similar phe-
notype. Cardiac MRI is an accurate tool to determine
typical cardiac involvement in the primal state of LMNA
cardiomyopathy and may help to initiate early treatment.
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Table 1 Myocardial delayed enhancement (DE) and
movement abnormalities in the left ventricle
Percentage of DE in
segments
Normal
movement (%)
Abnormal
movement (%)
Total
No enhancement 240 (99) 2 (1) 242
0-25% 12 (75) 4 (25) 16
26-50% 10 (50) 10 (50) 20
51-75% 0 (0) 6 (100) 6
76-100% 0 (0) 5 (100) 5
Total 262 27 289
Table 2 The Left ventricular volumes and function
parameters evaluated with MRI.
Males n=8 Females n=8 Controls n=14
(both females
and males)
BSA m
2 1.99 ± 0.20 1.80 ± 0.25 1.80 ± 0.2
LV EDV ml/m
2 109.83 ± 8.56 85.81 ± 11.54 80 ± 20
LV ESV ml/m
2 52.40 ± 16.32 34.15 ± 4.10 24 ± 7
SV ml/m
2 57.44 ± 14.97 51.65 ± 9.95 56 ± 13
EF% 52 ± 13 60 ± 0.05 70 ± 3
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